Showing results (231-240 of 270) with videos related to

Sort By:
Pageof 27
Molecular Imaging and Biology|October 31, 2013
A phase 2 study of 16α-[18F]-fluoro-17β-estradiol positron emission tomography (FES-PET) as a marker of hormone sensitivity in metastatic breast cancer (MBC)Lanell M Peterson, Brenda F Kurland, Erin K Schubert, et al.
Breast Cancer Research : BCR|November 10, 2023
Multimodal prediction of neoadjuvant treatment outcome by serial FDG PET and MRI in women with locally advanced breast cancerAnum S Kazerouni, Lanell M Peterson, Isaac Jenkins, et al.
The Lancet. Oncology|March 28, 2024
Gedatolisib in combination with palbociclib and endocrine therapy in women with hormone receptor-positive, HER2-negative advanced breast cancer: results from the dose expansion groups of an open-label, phase 1b studyRachel M Layman, Hyo S Han, Hope S Rugo, et al.
Cancer|February 15, 2023
Variation in second breast cancer risk after primary invasive cancer by time since primary cancer diagnosis and estrogen receptor statusKathryn P Lowry, Laura Ichikawa, Rebecca A Hubbard, et al.
Immunity|December 9, 1997
Early lethality, functional NF-kappaB activation, and increased sensitivity to TNF-induced cell death in TRAF2-deficient miceW C Yeh, A Shahinian, D Speiser, et al.
Basic Research in Cardiology|April 7, 2022
Regional analysis of inflammation and contractile function in reperfused acute myocardial infarction by in vivo 19F cardiovascular magnetic resonance in pigsFlorian Bönner, M Gastl, F Nienhaus, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 3, 2011
PET tumor metabolism in locally advanced breast cancer patients undergoing neoadjuvant chemotherapy: value of static versus kinetic measures of fluorodeoxyglucose uptakeLisa K Dunnwald, Robert K Doot, Jennifer M Specht, et al.
Clinical Breast Cancer|July 10, 2026
Tucatinib in Combination With Trastuzumab Deruxtecan in Patients With Previously Treated HER2+ Unresectable Locally Advanced or Metastatic Breast Cancer: An Open-Label Phase 2 StudyShanu Modi, Rashmi K Murthy, A Jo Chien, et al.
The Breast Journal|June 28, 2026
Real-World Practice Patterns in Diagnosis and First-Line Treatment in Metastatic Breast CancerPoorni M Manohar, Veena Shankaran, Nancy E Davidson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 13, 2010
Tumor metabolism and blood flow as assessed by positron emission tomography varies by tumor subtype in locally advanced breast cancerJennifer M Specht, Brenda F Kurland, Susan K Montgomery, et al.
Pageof 27